Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000258307

Medchemexpress LLC 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one | 1121931-70-1 | 99.9% | C23H29N3O3 | 10MG
SDP

Catalog No. 5000258307
Encompass_Preferred

CM398 is a selective, orally active sigma-2 receptor ligand used for receptor pharmacology and in vivo pain models. It has been characterized for receptor affinity and shows anti-inflammatory analgesic effects in preclinical studies.

  • High potency and selectivity for sigma-2 receptor (Ki = 0.43 nM).
  • Demonstrated efficacy in the formalin inflammatory pain model.
  • High purity suitable for research applications (99.85%).
  • Soluble in DMSO (100 mg/mL); supports multiple in vivo formulation options.
  • Stable under recommended storage conditions for long-term use.

Catalog No. 50-002-58307 Supplier Medchemexpress LLC Supplier No. HY14562810MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CM398 is a selective, orally active sigma-2 receptor ligand used for receptor pharmacology and in vivo pain models. It has been characterized for receptor affinity and shows anti-inflammatory analgesic effects in preclinical studies.

  • High potency and selectivity for sigma-2 receptor (Ki = 0.43 nM).
  • Demonstrated efficacy in the formalin inflammatory pain model.
  • High purity suitable for research applications (99.85%).
  • Soluble in DMSO (100 mg/mL); supports multiple in vivo formulation options.
  • Stable under recommended storage conditions for long-term use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.